Erik G. Almqvist

662 total citations
21 papers, 506 citations indexed

About

Erik G. Almqvist is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Erik G. Almqvist has authored 21 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Erik G. Almqvist's work include Parathyroid Disorders and Treatments (9 papers), Bone health and treatments (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Erik G. Almqvist is often cited by papers focused on Parathyroid Disorders and Treatments (9 papers), Bone health and treatments (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Erik G. Almqvist collaborates with scholars based in Sweden, United Kingdom and Belgium. Erik G. Almqvist's co-authors include Johan Svensson, Lennart Bondeson, Anne‐Greth Bondeson, Per Johansson, Kaj Blennow, Bo Wängberg, Henrik Zetterberg, Charlotte Becker, Anders Wallin and Sveneric Svensson and has published in prestigious journals such as PLoS ONE, British journal of surgery and Psychoneuroendocrinology.

In The Last Decade

Erik G. Almqvist

21 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik G. Almqvist Sweden 14 180 163 163 89 71 21 506
Mayuko Kadono Japan 13 96 0.5× 59 0.4× 268 1.6× 65 0.7× 144 2.0× 28 611
Laura Zinnamosca Italy 15 74 0.4× 366 2.2× 404 2.5× 48 0.5× 90 1.3× 29 756
Amanda J. Cox United States 16 62 0.3× 106 0.7× 196 1.2× 25 0.3× 96 1.4× 33 713
Yukari Mimura Japan 13 76 0.4× 82 0.5× 229 1.4× 41 0.5× 205 2.9× 41 610
Akira Ohtahara Japan 15 305 1.7× 170 1.0× 72 0.4× 126 1.4× 189 2.7× 40 714
Avraham Ishay Israel 13 73 0.4× 118 0.7× 192 1.2× 42 0.5× 87 1.2× 44 670
S. Cerci Italy 13 103 0.6× 93 0.6× 124 0.8× 31 0.3× 80 1.1× 30 433
Einosuke Mizuta Japan 14 270 1.5× 98 0.6× 49 0.3× 114 1.3× 279 3.9× 38 690
Janete Quelhas‐Santos Portugal 13 160 0.9× 64 0.4× 57 0.3× 73 0.8× 345 4.9× 36 596
Fumiko Kawakami-Mori Japan 11 184 1.0× 71 0.4× 176 1.1× 40 0.4× 217 3.1× 12 604

Countries citing papers authored by Erik G. Almqvist

Since Specialization
Citations

This map shows the geographic impact of Erik G. Almqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik G. Almqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik G. Almqvist more than expected).

Fields of papers citing papers by Erik G. Almqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik G. Almqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik G. Almqvist. The network helps show where Erik G. Almqvist may publish in the future.

Co-authorship network of co-authors of Erik G. Almqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Erik G. Almqvist. A scholar is included among the top collaborators of Erik G. Almqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik G. Almqvist. Erik G. Almqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansson, Per, Erik G. Almqvist, Anders Wallin, et al.. (2017). Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment. PLoS ONE. 12(5). e0176760–e0176760. 14 indexed citations
2.
Johansson, Per, Erik G. Almqvist, Maria Bjerke, et al.. (2017). Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer’s Disease. Journal of Alzheimer s Disease. 59(3). 1017–1026. 29 indexed citations
3.
Johansson, Per, Erik G. Almqvist, Anders Wallin, et al.. (2015). Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease. Neuroscience Letters. 609. 58–62. 18 indexed citations
4.
Ragnarsson, Óskar, Camilla A M Glad, Ragnhildur Bergthorsdottir, et al.. (2014). Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity. European Journal of Endocrinology. 172(1). 1–10. 23 indexed citations
5.
Johansson, Per, Erik G. Almqvist, Per Johansson, et al.. (2013). Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease. PLoS ONE. 8(11). e81989–e81989. 43 indexed citations
6.
Eggertsen, Robert, et al.. (2013). Long-term follow-up of patients with elevated serum calcium concentrations in Swedish primary care. Scandinavian Journal of Primary Health Care. 31(4). 248–254. 10 indexed citations
7.
Johansson, Per, Erik G. Almqvist, Per Johansson, et al.. (2012). Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease. Psychoneuroendocrinology. 38(7). 1058–1066. 40 indexed citations
8.
Bondeson, Anne‐Greth, et al.. (2012). The association between the IGF-I axis, thyroid hormones and cortical bone in patients with mild primary hyperparathyroidism. Scandinavian Journal of Clinical and Laboratory Investigation. 73(1). 34–41. 1 indexed citations
9.
Muth, Andreas, et al.. (2011). Adrenal lesions in patients with extra-adrenal malignancy – benign or malignant?. Acta Oncologica. 51(2). 215–221. 14 indexed citations
10.
Almqvist, Erik G., Anne‐Greth Bondeson, Lennart Bondeson, Dan Mellström, & Johan Svensson. (2011). Factors influencing insulin sensitivity in patients with mild primary hyperparathyroidism before and after parathyroidectomy. Scandinavian Journal of Clinical and Laboratory Investigation. 72(2). 92–99. 23 indexed citations
11.
Muth, Andreas, et al.. (2011). Cohort study of patients with adrenal lesions discovered incidentally. British journal of surgery. 98(10). 1383–1391. 41 indexed citations
12.
Almqvist, Erik G., et al.. (2010). Solving the ADAPT Benchmark Problem - A Student Project Study. Annual Conference of the PHM Society. 2(2). 4 indexed citations
13.
Almqvist, Erik G., Anne‐Greth Bondeson, Lennart Bondeson, & Johan Svensson. (2010). Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism. Scandinavian Journal of Clinical and Laboratory Investigation. 71(2). 139–144. 31 indexed citations
14.
Muth, Andreas, Bo Wängberg, Lena Björneld, et al.. (2010). Adrenal lesion frequency: A prospective, cross-sectional CT study in a defined region, including systematic re-evaluation. Acta Radiologica. 51(10). 1149–1156. 45 indexed citations
15.
Almqvist, Erik G., Charlotte Becker, Anne‐Greth Bondeson, et al.. (2006). Increased plasma concentrations of N‐terminal pro‐B‐type natriuretic peptide in patients with mild primary hyperparathyroidism. Clinical Endocrinology. 65(6). 760–766. 7 indexed citations
16.
Almqvist, Erik G., Charlotte Becker, Anne‐Greth Bondeson, Lennart Bondeson, & Johan Svensson. (2005). Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women. Clinical Endocrinology. 64(1). 58–62. 9 indexed citations
17.
Almqvist, Erik G., Charlotte Becker, Anne‐Greth Bondeson, Lennart Bondeson, & Johan Svensson. (2004). Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: A prospective and randomized study. Surgery. 136(6). 1281–1288. 58 indexed citations
18.
19.
Almqvist, Erik G.. (2001). Hypothalamic-pituitary-adrenal response to different tests in type 1 diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation. 61(7). 557–565. 2 indexed citations
20.
Almqvist, Erik G., Leif Groop, & Per Manhem. (1999). Growth hormone response to the insulin tolerance and clonidine tests in type 1 diabetes. Scandinavian Journal of Clinical and Laboratory Investigation. 59(5). 375–382. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mayuko Kadono Breakdown of academic impact, for papers by Laura Zinnamosca Breakdown of academic impact, for papers by Amanda J. Cox Breakdown of academic impact, for papers by Yukari Mimura Breakdown of academic impact, for papers by Akira Ohtahara Breakdown of academic impact, for papers by Avraham Ishay Breakdown of academic impact, for papers by S. Cerci Breakdown of academic impact, for papers by Einosuke Mizuta Breakdown of academic impact, for papers by Janete Quelhas‐Santos Breakdown of academic impact, for papers by Fumiko Kawakami-Mori
Rankless by CCL
2026